BridgeMD
Compares treatment options for Prosthetic-joint Infection
Official title Real-component vs All-cement Articulating Spacers for Periprosthetic Knee Infection
ClinicalTrials.gov ID: NCT06293352
What this study is testing
- What it's testing
- In the US, if an infection in an artificial knee joint doesn't heal with antibiotics alone, the standard treatment is a two-stage revision of the artificial knee. In the first stage, the surgeon will remove the artificial knee and clean out the area around the knee.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients diagnosed with a chronic periprosthetic joint infection after a primary total knee arthroplasty with plan for explant and placement of an...
- PJI defined according to Musculoskeletal Infection Society (MSIS) 2018 Consensus Criteria
You likely can't join if
- Patients who are unable to consent
- Infection at site of revision TKA
- Soft tissue envelope compromise
- Allergies to study materials (cement, vancomycin, tobramycin)
- Incompetent extensor mechanism
- Extensive bone loss Randomization-specific exclusion criteria
See the full eligibility criteria
- Patients diagnosed with a chronic periprosthetic joint infection after a primary total knee arthroplasty with plan for explant and placement of an antibiotic spacer
- PJI defined according to Musculoskeletal Infection Society (MSIS) 2018 Consensus Criteria
- Patients who are unable to consent
- Infection at site of revision TKA
- Soft tissue envelope compromise
- Allergies to study materials (cement, vancomycin, tobramycin)
- Incompetent extensor mechanism
- Extensive bone loss Randomization-specific exclusion criteria
- Extensive soft tissue defect
- Extensor mechanism compromise
The study team makes the final eligibility decision.
Where it's taking place
- Chicago, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chicago, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.